Lansion Biotechnology Co., Ltd.

Lansion Biotechnology Co., Ltd.

(Lansionbio) is a biotechnology company based in Nanjing, China, established in 2016. The company specializes in the research, development, production, and sale of in vitro diagnostic (IVD) reagents and point-of-care testing (POCT) devices. Lansionbio operates a 20,000-square-meter R&D center, which includes a GMP-standard aseptic purification cleanroom, and is an ISO13485-certified manufacturer with over 200 patents. Lansionbio offers a range of products, including diagnostic analyzers, POCT devices, and IVD reagents for various health conditions. Their solutions cater to both B2B clients, such as healthcare institutions and diagnostic centers, and B2C clients, including families using home-based testing kits. The company exports to more than 50 countries and has been actively involved in global COVID-19 prevention efforts since 2020. Lansionbio is committed to advancing point-of-care diagnostics and improving human health through innovative products.